Nebracetam – (97205-34-0)

Nebracetam is an investigational nootropic drug belonging to the racetam family, known for its potential as an M1 acetylcholine receptor agonist. Initially studied in rats, it has shown promise in enhancing cognitive function, similar to other racetams like piracetam and aniracetam.

Research conducted in 1991 suggested its effectiveness as a human M1-muscarinic receptor agonist, indicating its potential in improving memory and learning. Despite its promising profile, nebracetam has not yet undergone human clinical trials as of 2025.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

https://en.wikipedia.org/wiki/Nebracetam
https://www2.medchemexpress.com/nebracetam-hydrochloride.html
https://www.medkoo.com/products/19831
https://www.sciencedirect.com/science/article/pii/S0021519819520856
https://drugs.ncats.io/substance/3GPZ0A8OW9